These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9764905)

  • 1. Association between a defective CCR-5 gene and progression to disease in HIV infection.
    Balfe P; Churcher Y; Penny M; Easterbrook PJ; Goodall RL; Galpin S; Gotch F; Daniels RS; McKeating JA
    AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1229-34. PubMed ID: 9764905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
    Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
    AIDS; 1998 May; 12(7):729-36. PubMed ID: 9619804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of MT-2 tropism on the prognostic implications of the delta32 deletion in the CCR-5 gene.
    Bratt G; Sandström E; Albert J; Samson M; Wahren B
    AIDS; 1997 Oct; 11(12):1415-9. PubMed ID: 9342063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation.
    Crotti A; Neri F; Corti D; Ghezzi S; Heltai S; Baur A; Poli G; Santagostino E; Vicenzi E
    J Virol; 2006 Nov; 80(21):10663-74. PubMed ID: 16943296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 disease progression, CCR5 genotype, and specific immune responses.
    Visco-Comandini U; Hultgren C; Broström C; Birk M; Kim S; Sällberg M
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):463-6. PubMed ID: 9665949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group.
    Stewart GJ; Ashton LJ; Biti RA; Ffrench RA; Bennetts BH; Newcombe NR; Benson EM; Carr A; Cooper DA; Kaldor JM
    AIDS; 1997 Dec; 11(15):1833-8. PubMed ID: 9412701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission.
    Lockett SF; Alonso A; Wyld R; Martin MP; Robertson JR; Gore SM; Leen CL; Brettle RP; Yirrell DL; Carrington M; Brown AJ
    J Infect Dis; 1999 Sep; 180(3):614-21. PubMed ID: 10438347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
    J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of a mutated CCR-5 allele (delta32) among Italian healthy donors and individuals at risk of parenteral HIV infection.
    Zamarchi R; Indraccolo S; Minuzzo S; Coppola V; Gringeri A; Santagostino E; Vicenzi E; De Silvestro G; Biagiotti R; Baldassarre C; Chieco-Bianchi L; Amadori A
    AIDS Res Hum Retroviruses; 1999 Mar; 15(4):337-44. PubMed ID: 10082117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequency of the mutated allele of CCR-5 receptor in HIV-1 positive and negative individuals in the Province of Chaco].
    Motta P; Cibulsky L; Iliovich E; Habegger de Sorrentino A
    Medicina (B Aires); 2000; 60(4):431-4. PubMed ID: 11188946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors.
    Walli R; Reinhart B; Luckow B; Lederer E; Loch O; Malo A; Wank R; Schlöndorff D; Goebel FD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):229-33. PubMed ID: 9665499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
    Paxton WA; Kang S; Koup RA
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CCR5delta32 host genetic background and disease progression on HIV-1 intrahost evolutionary processes: efficient hypothesis testing through hierarchical phylogenetic models.
    Edo-Matas D; Lemey P; Tom JA; Serna-Bolea C; van den Blink AE; van 't Wout AB; Schuitemaker H; Suchard MA
    Mol Biol Evol; 2011 May; 28(5):1605-16. PubMed ID: 21135151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors.
    Menzo S; Sampaolesi R; Vicenzi E; Santagostino E; Liuzzi G; Chirianni A; Piazza M; Cohen OJ; Bagnarelli P; Clementi M
    AIDS; 1998 Jun; 12(9):985-97. PubMed ID: 9662194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
    Salem AH; Batzer MA
    Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand.
    McCutchan FE; Viputtigul K; de Souza MS; Carr JK; Markowitz LE; Buapunth P; McNeil JG; Robb ML; Nitayaphan S; Birx DL; Brown AE
    AIDS Res Hum Retroviruses; 2000 May; 16(8):801-5. PubMed ID: 10826486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression.
    Tang J; Rivers C; Karita E; Costello C; Allen S; Fultz PN; Schoenbaum EE; Kaslow RA
    Genes Immun; 1999 Sep; 1(1):20-7. PubMed ID: 11197301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.